The human a-globin-like embryonic I;-globin chains are present in abundance during the first 5 to 6 weeks of gestation. Subsequently, &-globin chains are present in fetal blood at a very low level, which is supplanted by the expression of a-globin chains. Adult individuals who are carriers of the (--SEA/) D
a-thalassemia deletion, in contrast
to normal adults, have low levels of embryonic &-globin chains in their circulating erythrocytes.
In this investigation, we constructed stable mouse-human hybrid cells with murine erythroleukemia cells bearing human chromosome 16, with either the normal a-globin gene cluster (am/) or the (--sEA/I URING HUMAN EMBRYONIC and fetal development, there are orderly changes from embryonic to fetal and later to adult hemoglobins.'.' These alterations are caused by the sequential activation of genes in the aand &globin gene clusters on the short arms of chromosomes 16 and 1 1, respectively. The human a-globin gene cluster normally consists of seven globin genes arranged in the order of 5'-<2-!V<1-G"(r2-~al1-a2-al-81-3' comprising approximately 30 kb on the short arm of chromosome 16 (Fig 1) .
There are a number of known deletional mutations involving this globin gene cluster leading to the syndrome of a-thalas-~e m i a .~ In Southeast Asia, the most prevalent a-thalassemia mutation is the deletion of approximately 20.5 kb involving all the a-globin genes and the 81-gene as well; this mutation is designated as the (- deletion. The 5"breakpoint of this deletion is located approximately 11 kb 3' downstream of the 62-globin gene. We have previously observed that adult carriers of the (- deletion have minute amounts of embryonic <-globin chains in their circulating erythroc y t e~.~.~ To show that the embryonic <-globin gene can be expressed under the influence of adult erythroid trans-acting factors and to determine the effect of the (--SEA) deletion on <-globin gene expression, we constructed stable mousehuman hybrid cells with murine erythroleukemia cells (MEL) bearing human chromosome 16, with either the normal a-globin gene cluster ( a d ) or the (--SEA/) type of athalassemia deletion. The parental murine erythroleukemia cell line synthesizes adult hemoglobins, with or without induction. In hybrid cell lines containing the human chromo- some 16 with the deletion, human <-globin mRNA is present and, on induction, is markedly increased, in parallel with the induction of the endogenous murine a-globin mRNA. This study provides direct evidence that the expression of <-globin gene in cis to the (--SEA/) deletion accounts for the presence of low-level <-globin chains observed in adult carriers of the (--SEA/) deletion."6 Furthermore, these observations illustrate the importance of the DNA sequences within the (--SEAI) deletion in regulating the expression of <-globin gene in cis.
MATERIALS AND METHODS

Construction of hybrid cell lines.
The tetraploid murine erythroleukemia cell line, MEL-179, which is deficient in adenine phosphoribosyl transferase (APRT), was cultured in RPM1 1640 with 10% fetal calf serum (FCS) and 100 ,ug/mL 2,6-diaminopurine.' The parental human cells were peripheral blood mononuclear cells (MNC) from normal and a-thalassemia heterozygous adults, human fetal hepatic erythroblasts (HFHE) from homozygous a-thalassemia fetuses, and human K562 cells that express an embryonic/fetal hemoglobin synthetic program.'
Cell fusion was performed with polyethylene glycol (No. 779512; Boehringer Mannheim, Indianapolis, IN) as previously de-Hybrids were selected for APRT activity by culturing in medium containing adenine and alanosine with 10% FCS. The gene coding for the APRT is on the long arm of human chromosome 16. Fusion of K562 and MEL-179 cells was selected for the presence of APRT activity and resistance to ouabain." The hybrid cell colonies were first screened by DNA slot blot assay using "P-labeled human Alu probe. All hybrid cell lines were later subcloned and subjected to Southern blot analysis of the human a-globin gene cluster as well as the human chromosome 16 centromere-specific repetitive sequences, D16Z2.'' Karyotyping was also performed in a number of the hybrid cell lines. All hybrid cells were cultured in selection media for more than 6 months before analysis of globin mRNA expression was undertaken.
Determinations of globin mRNAs. Hybrid cells were induced with either 1% dimethylsulfoxide (DMSO) or 5 mmol/L hexamethylene bisacetamide (HMBA). Total cellular RNA was extracted from 1 to 2 x lo8 cultured cells by the guanidiniudcesium chloride method. The poly-A-rich RNA was isolated from cellular RNA by a single cycle of oligo-dT-cellulose column chromatography.
Globin mRNAs were determined by S1 nuclease protection assays." The a-'*P-dCTP (6,000 Ci/mmol; Amersham, Arlington Heights, IL) was used for 3'-end labeling by the Klenow DNA polymerase reaction. The y3'P-ATP (5,000 Ci/mol; Amersham) was used for 5'-end labeling by T4 polynucleotide kinase. The antisense strand of each probe (except M&MG probe) was isolated by Hood, Vol 86, NO 3 (August l), 1995 pp 1212-1217
For personal use only. on August 16, 2017. by guest www.bloodjournal.org From S% polyacrylamide gel. The single-stranded cDNA probe (at 1 X IO' cpm) was added in excess to each S 1 nuclease protection assay. Hybridization was performed at 4S"C (SOT for M&-MG) overnight. A total of 40 to 80 U of SI nuclease (Pharmacia 270-920-01; Pharmacia, Uppsala. Sweden) was added to each reaction and incubated at 37°C for 30 minutes. After the reaction, DNA was precipitated by ethanol. analyzed by electrophoresis on a 4 8 urea polyacrylamide gel, and visualized by autoradiography at -70°C for I O to 30 days using intensifying screens.
Human <-globin mRNA protects a 320-111 fragment of the 3'-end labeled 520-nt probe, an Qrrantitatiorl of human &-globin mRNA copies. In an attempt to quantitate <-globin mRNA in hybrid cells. the human <-globin cDNA was subcloned into pGEM-47, vector (Promega, Madison. WI) at the f s r I site. and a large amount of human <-globin mRNA was synthesized using the Promega in vitro transcription kit. After treatment with RQI DNase 1 (M610A: Promega). the synthesized human <-globin mRNA was purified by Sephadex G-S0 column chromatography, phenol extraction, and ethanol precipitation. The concentration of synthesized <-globin mRNA was measured by spectrophotometry and was further confirmed by electrophoresis on 2% agarose gel and comparing with rabbit globin mRNA (8103SB: BRL, Gaithersburg, MD) as a standard. Density of the bands stained with ethidium bromide was scanned by densitometer UltroScan XL (Bio-Rad. Richmond. CA). Serial dilutions of the synthesized human <-globin mRNA with known amount of <-globin mRNA copies were used as standards in each S I nuclease assay. The density of protected fragment on the radioautograph was scanned by densitometer. The numbers of <-globin mRNA copies in the samples were then calculated by Comparison with the synthesized &-globin mRNA standards using the Minitab statistical analysis program (Minitab Inc, State College, PA). Mouse /32-microglobulin mRNA was also determined in each poly-A-rich RNA sample to normalize data from different experiments to correct for variations in the efficiency of poly-Arich RNA isolation and recovery.
RESULTS
Qunntitntion of klrrnan <-globin InRNA. Serial dilutions
of the synthesized human <-globin mRNA were assayed by S 1 nuclease protection analysis. A linear correlation between the signal intensities of the protected fragments and the cglobin mRNA copies varying between 2 X IO' to 4 X IO9 was observed (data not shown). In addition, RNA preparations from induced and uninduced K562 cells were similarly studied. The data indicate that the K562 cell line maintained in our laboratory has approximately 5 X IO' copies of <globin mRNA per microgram of total cellular RNA. With induction by 40 pmol/L hemin for 3 days, the <-globin mRNA level increased to approximately IO-fold higher. In two separate determinations, the <-globin mRNA copy number present in HFHE from midgestation homozygous a-thalassemia fetuses was found to be similar to that present in induced K562 cells, ie, 5 X IOx copieslyg of cellular RNA (data not shown).
The mouse P1-microglobulin mRNA level remained relatively stable in mouse-human hybrid cells, with or without induction (Fig 2) . Therefore, mouse &microglobulin mRNA level was determined in each poly-A-rich RNA sample to normalize results from different experiments to correct for variations in the efficiency of poly-A-rich RNA isolation and recovery.
MEL X M N C (ad) hybrids. Seven hybrid cell lines, each containing human chromosome 16 with normal a-globin gene cluster derived from adult MNC, were studied. Four of these cell lines were constructed with MNC from two normal adult individuals (aa/aa), whereas the other three cell lines were constructed with MNC from two other individuals who were carriers of the a-thalassemia deletion (--"%a).
Ten different RNA samples were extracted from these seven cell lines ( Table l ) in six other samples. Human <-globin mRNA was detectable in all seven hybrid cell lines with induction by either DMSO or HMBA.
These results show that a very minute amount of human <-globin mRNA is present in the hybrid cells containing human chromosome 16 with the normal a-globin gene cluster. To determine if there was cellular heterogeneity in the ability to express human <-globin gene in these hybrid cells, we have further subcloned two of these cell lines; all five subclones tested were found to have similarly low levels of human <-globin gene expression (data not shown). These data are consistent with the recent finding that <-globin mRNA is detectable in normal adult reticulocytes by highly sensitive methods." Results from previous reports showing that <-globin mRNA was not present in similarly constructed and induced hybrid cells might be caused by the sensitivity of the assay methods used."," MEL X MNC (--""/) hvhrid.v. Three hybrid cell lines, each containing human chromosome 16 with the (--"'"/) deletion, derived from an adult a-thalassemia carrier MNC were also investigated. As shown in Figs 3 and 4, (-globin mRNA levels were determined to be 5.3 2 2.8 X 10' copied p g RNA in four separate RNA samples. Again, induction by either DMSO or HMBA led to a moderate increase in human (-globin mRNA expression in these hybrid cells (Table l).
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HUMAN EMBRYONIC <-GLOBIN GENE EXPRESSION
These data suggest that the human <-globin gene expression is higher in hybrids containing the human chromosome 16 with the (--'""/) deletion when compared with that of hybrids with normal human chromosome 16. Furthermore, induction with either DMSO or HMBA can enhance the human <-globin gene expression in these hybrid cells. However, the level of human <-globin mRNA present in these hybrid cells, even with induction, is relatively low in comparison with the levels observed in MEL X HFHE (--""'/) hybrids (see below and Fig 4) . It is known that the human adult globin gene expression in the chromosome-mediated gene transfer experiments depends on the differentiated state of human donor c e k 7 If the donor cells are nonerythroid hematopoietic cells, as in the aforementioned experiments, human adult globin gene expression is much less than that in hybrid cells constructed with human erythroid c e k 7 M E L X K562 (ad) hybrids. It should be informative to determine the pattern of human embryonic <-globin gene expression in MEL-human hybrid erythroid cell lines constructed with normal midgestation human fetal erythroblasts. However, these human fetal cells are not readily available. Instead, we elected to use the human K562 erythroleukemic cell line as the human parental cells in constructing the mouse-human hybrid erythroid cell lines. Whereas K562 cells are erythroleukemic and not normal fetal erythroblasts, these cells are active in embryonic and fetal globin gene expression. During normal human fetal development, the embryonic <-globin gene expression is minimal during the second and third trimester of pregnancy.'.2 In contrast, as presented above, induced K562 cells contain similar copies of <-globin mRNA as in fetal hepatic erythroblasts from midgestation human fetuses with homozygous a-thalassemia Two MEL X K562 ( a d ) hybrid cell lines were constructed and studied in detail. Southern blot analysis showed that they contained the normal human a-globin gene cluster. In one hybrid cell line, karyotyping was performed and one copy of normal human chromosome 16 was found to be present. In concert with previously published data," these hybrids had very few human <-globin mRNA, with a mean of 3.7 ? 1.5 X IO' copies/pg RNA in four different RNA samples. Induction with DMSO or HMBA resulted in a minimal increase in the level of human <-globin mRNA ( Table  l) . On the other hand, human a-globin gene expression in these hybrids was significantly enhanced by DMSO or HMBA, in parallel with the induction of the endogenous murine a-globin gene expression ( Fig S) . These results show that the chromosomal transfer of a transcriptionally active human <-globin gene linked to normal a-globin genes in cis, from the embryonic erythroid milieu of the K562 cells into the adult erythroid cell environment of the MEL cells, causes suppression of the human <-globin gene expression.
MEL X HFHE (--'l'') hvhrids. To construct hybrid cell lines with human erythroid cells that express the <-globin gene but from which the a-globin genes have been deleted, we next obtained fetal liver tissues from two midgestation fetuses with homozygous a-thalassemia at postmortem examination. Single-cell suspension of HFHE was prepared and used to construct eight hybrid cell lines with MEL-179. 1.2, and 3 , hybrid cells induced with HMBA for 1,2, or 3 days, respectively; lane A5, hybrid cells induced with HMBA for 3 days followed by culture for 5 additional days without HMBA. The MEL x HFHE hybrid cells did not have detectable human m-globin mRNA with or without induction.
All were shown by Southern blot analysis to contain human a-globin gene cluster with the (--'"'/) deletion. In two hybrid cell lines, karyotyping was performed, and each line was found to contain one copy of human chromosome 16. Human <-globin mRNA was present in all eight hybrid cell lines, with a mean of 7.8 ? 1.0 X 10' copies/pg RNA, as assessed in nine different RNA samples (Figs 3 through 5) . Induction by DMSO or HMBA resulted in a significantly increased human <-globin mRNA level, with a mean of 27.5 t 9.8 and 33.9 ? 9.0 X I O 3 copies/pg RNA, respectively. The presence of mouse <-globin mRNA was searched for in these hybrids and not found, suggesting that the hybrid cells do not have embryonic erythroid frons-acting factors. On the other hand, the induction of human <-globin gene expression in these hybrid cells was in parallel with the induction of the endogenous murine a-globin gene expression (Fig 3 , indicating that human <-globin gene expression in these cells a-thalessemia deletion are expressed in adult erythroid tissues.
DISCUSSION
The present observations, together with previously published results, suggest that MEL cells produce the adult type of erythroid trans-acting factors intracellularly, which can affect the expression of endogenous murine a-globin genes as well as the transferred human a-globin genes in the hybrid cells but not significant expression of embryonic <-globin fetal type of erythroid trans-acting factors, thus allowing the expression of embryonic and fetal globin genes.'*" The present investigation also shows that, in MEL hybridcells containing human chromosome 16 with the deletion, human <-globin gene in cis to the deletion is expressed, albeit at low level. Furthermore, the human 5globin gene expression can be increased by induction to levels much higher than the constitutive level, in parallel with the induction of endogenous murine a-globin gene expression. These data are consistent with the observation that low-level <-globin chain expression is present in the circulating erythrocytes of an adult carrier of the (--SEA/) deletion:"
The level of human <-globin gene expression in MEL X HFHE hybrid cells is very low. There are approximately 3.4 X lo4 copies of human <-globin mRNA per microgram of cellular RNA in these hybrids after induction with HMBA for 3 days (Table 1 and Fig 4) . In contrast, there are approximately 5 X 1 0 ' copies of <-globin mRNA per microgram of cellular RNA in K562 cells induced with hemin for 3 days as well as in HFHE from midgestation homozygous a-thalassemia (-
fetuses. Therefore, the major factors that allow high-level human embryonic <-globin gene expression are lacking in the MEL cells, which could not be compensated merely by the (--SEA/) type of a-thalassemia deletion in cis.
Recent studies have shown that the developmental stagespecific and tissue-specific regulation of globin gene expression is achieved through the interaction of at least three elements. These elements include both positive and negative regulatory nucleotide sequences flanking the coding sequences of the globin Secondly, the distal major regulatory sequences, the locus control region of the p-globin gene cluster, and the HS-40 major regulatory region of the a-globin gene cluster are indispensable in globin gene Thirdly, it is generally thought that erythroidspecific trans-acting factors are responsible for the developmental stage-specific regulation of globin gene expres-Our present data suggest that, in the presence of the athalassemia deletion in regulating the expression of embryonic <-globin gene in cis.
It was recently reported that, using the transgenic mouse model, human <-globin gene expression was present only in the murine yolk sac erythroid cells and not in the fetal liverderived erythroblasts, even when the constructs did not contain human a-globin genes in These results were interpreted to show the autonomous developmental regulation of human <-globin gene expression. However, human <-globin genes are expressed at a very high level, as late as in the third trimester fetuses with homozygous a-thalassemia caused by the (--SEA/)
Cord blood of newborns who are heterozygous for the (- deletion has approximately 10 times more <-globin chains than that of normal newborns2 Adult carriers of the (--SEA/) deletion have lowlevel <-globin chains in their peripheral b l~o d .~.~ Furthermore, the pattern of human embryonic t-globin gene expression during embryonic development in transgenic mice was recently shown to be different from the normal pattern observed in human e r n b r y o~.~,~~ Taken together, these observations indicate that the current interpretation of the transgenic mouse experiments with regard to the <-globin gene regulation during human development might need modifications.
Individuals who are carriers of the (-and (--SPAN/) a-thalassemia deletions involving a-globin genes also have detectable <-globin chains in their circulating erythrocytes.' However, not all the natural deletions are accompanied by the low-level <-globin gene expression in adult carriers. For example, adult carriers of (--BR'T/), and [--(a)20.5/] deletions do not have detectable <-globin chains in their peripheral blood (Fig l) .' These observations suggest that the nucleotide sequences spanning approximately 5 kb between the 5' breakpoints of the (--SA/) and the (--SEA/)
deletions are necessary to ensure the low-level expression of embryonic <-globin gene in cis to the (--SEA/) deletion in adult carriers.6 These data also make it highly unlikely that there might be enhancer-like sequences present 3' to the deletion.6 Taken together, these results indicate that the human embryonic <globin gene expression is modulated during development by multiple positive and negative regulatory mechanisms. The data of the present investigation provide support for the hypothesis that some DNA sequences within the (--SEA/) athalassemia deletion are essential in affecting the lack of significant <-globin gene expression in normal adult erythroid cells. It may be speculated that this effect is mediated through the competition between <and a-globin genes in cis for the interaction with HS-40 major regulatory region and the stage-specific erythroid trans-acting factors.
